Clinical Trials
Total Trials
11
As Lead Sponsor
0
As Collaborator
Total Enrollment
596
NCT02087670
Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program
Phase: N/A
Role: Collaborator
Start: Mar 31, 2005
Completion: Jan 31, 2008
NCT02106650
Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies
Phase: Phase 2
Start: Jul 31, 2014
Completion: Jun 30, 2019
NCT02820675
Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions
Start: Aug 31, 2015
Completion: Jul 31, 2019
NCT02594267
A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)
Phase: Phase 1
Start: Nov 10, 2015
Completion: Oct 8, 2020
NCT02679131
To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.
Start: Mar 31, 2016
Completion: Jun 30, 2017
NCT02680795
Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes
Start: Apr 27, 2016
Completion: Jul 21, 2020
NCT03636659
Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition
Start: May 2, 2018
Completion: Apr 5, 2019
NCT04184869
Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials
Start: Aug 5, 2019
Completion: Mar 31, 2023
NCT04245813
Effectiveness of a Cardiac Rehabilitation Program in Patients With Heart Failure
Start: Dec 23, 2019
Completion: May 15, 2023
NCT04243434
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Start: Aug 15, 2020
Completion: Oct 15, 2020
NCT05433896
Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions
Start: Nov 1, 2020
Completion: Dec 19, 2020
Loading map...